Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • cvhove
    Junior Member
    • May 2011
    • 3

    #1

    RNA-seq: rRNA Depletion, Double riboZero or Double RiboMinus

    Hi,
    I did a RNA-seq sample on Illumina GA2x: 15 years old Tumor FFPE sample. The RNA extraction give a very low RIN score analysing on the BioAnalyser RIN +/-1.5.
    I used the EPICENTRE combination of RIBO-ZERO with SCRIPTSEQ v2. Good results 30-50% mapped reads, but still 35% related to rRNA. Is there a protocol to remove more rRNA out of the sample. Doing the Depletion twice, combinations Ribo-Zero with RiboMinus or other manors to increase the mapped reads?
    thanks
    c
  • JakobHedegaard
    Member
    • Mar 2008
    • 62

    #2
    Hi cvhove,
    We have also done RNA-Seq on old (up to 20 years) tumor FFPE samples using Ribo-Zero in combination with ScriptSeq. In general we see 70-90% of the reads mapping to the human transcriptome set from ensembl (not including rRNA) and a variable fraction of the un-mapped reads mapping to rRNA after de-novo assembly.
    Be aware that the rRNA reads can be due to 1) insufficient removal of rRNA during Ribo-Zero, or 2) "leaking" of the Ribo-Zero probes into ScriptSeq resulting in rRNA reads. Try to contact Epicentre for support.
    Cheers, Jakob

    Comment

    • ZWB
      Member
      • Apr 2011
      • 27

      #3
      Hello,

      We have had very good luck removing rRNA from degraded samples using DSN treatment. In degraded samples we find that DSN works much better than Ribo-Zero often dropping the final rRNA to <5%. I would strongly recommend against multiple rounds of Ribo-Zero as we have lost entire samples attempting it.

      Comment

      • JakobHedegaard
        Member
        • Mar 2008
        • 62

        #4
        Hi zwb,
        We were also considering DSN, but skipped it due to the potentiel effects on higly expressed transcripts. Have you tried to compare profiles of DSN vs non-DSN to see if the expression levels of highly expressed transcripts are underestimated in DSN?
        /Jakob

        Comment

        • ZWB
          Member
          • Apr 2011
          • 27

          #5
          We find that the most highly expressed genes are still the most highly expressed genes after DSN treamtent. So if you look at a metric like the top 10 most highly expressed genes before and after DSN the lists contain the same genes in the same order. While the expression levels of the most highly expressed genes do even out somewhat, it seems like the vast majority of what you are removing is rRNA and not the mRNA you are interested in. In addition, we find many hundreds of low expression level genes that we were not able to see before regardless of sequencing depth. I hope this helps.

          ZWB

          Comment

          • ehdezsanabria
            Junior Member
            • Aug 2014
            • 3

            #6
            Hi Jakob,
            We used the Turbo DNase from Ambion and followed by clean-up with RNAeasy mini kit. Then we used the Terminator exonuclease (because we do not have access to the RiboZero kit) and constructed the libraries with the ScriptSeq kit. Of course our results were not good and the libraries were degraded. Any advice on how to deplete the RNA without using Ribozero? I am planning to remove the RNA with the on-column protocol from the RNAeasy mini kit from Qiagen. However, I am not sure if I can directly proceed to the library construction without depleting. Thanks a lot for your advice!!

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            27 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            28 views
            0 reactions
            Last Post SEQadmin2  
            Working...